AU2003239777A1 - Multimerised growth hormone fusion proteins - Google Patents

Multimerised growth hormone fusion proteins

Info

Publication number
AU2003239777A1
AU2003239777A1 AU2003239777A AU2003239777A AU2003239777A1 AU 2003239777 A1 AU2003239777 A1 AU 2003239777A1 AU 2003239777 A AU2003239777 A AU 2003239777A AU 2003239777 A AU2003239777 A AU 2003239777A AU 2003239777 A1 AU2003239777 A1 AU 2003239777A1
Authority
AU
Australia
Prior art keywords
multimerised
fusion proteins
growth hormone
hormone fusion
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003239777A
Other versions
AU2003239777A8 (en
Inventor
Thor Las Holtet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Bio Denmark AS
Original Assignee
Roche Bio Denmark AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Bio Denmark AS filed Critical Roche Bio Denmark AS
Publication of AU2003239777A1 publication Critical patent/AU2003239777A1/en
Publication of AU2003239777A8 publication Critical patent/AU2003239777A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726—Lectins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormones [GH] (Somatotropin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
AU2003239777A 2002-07-05 2003-06-23 Multimerised growth hormone fusion proteins Abandoned AU2003239777A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US39338302P 2002-07-05 2002-07-05
US60/393,383 2002-07-05
DKPA200201062 2002-07-05
DKPA200201062 2002-07-05
PCT/DK2003/000428 WO2004005335A2 (en) 2002-07-05 2003-06-23 Multimerised growth hormone fusion proteins

Publications (2)

Publication Number Publication Date
AU2003239777A1 true AU2003239777A1 (en) 2004-01-23
AU2003239777A8 AU2003239777A8 (en) 2004-01-23

Family

ID=30116815

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003239777A Abandoned AU2003239777A1 (en) 2002-07-05 2003-06-23 Multimerised growth hormone fusion proteins

Country Status (2)

Country Link
AU (1) AU2003239777A1 (en)
WO (1) WO2004005335A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5537946B2 (en) 2006-11-22 2014-07-02 ブリストル−マイヤーズ スクイブ カンパニー Targeted therapeutic agents based on modified proteins for tyrosine kinase receptors including IGF-IR
WO2009142773A2 (en) 2008-05-22 2009-11-26 Bristol-Myers Squibb Company Multivalent fibronectin based scaffold domain proteins
JP6207507B2 (en) * 2011-08-25 2017-10-04 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ Shortened tetranectin-apolipoprotein AI fusion protein, lipid particles containing the same, and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE274064T1 (en) * 1995-05-23 2004-09-15 Morphosys Ag MULTIMER PROTEINS
GB9526733D0 (en) * 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
AU736707B2 (en) * 1997-06-11 2001-08-02 Anaphore, Inc. Trimerising module
AU2002221568B2 (en) * 2000-12-13 2005-06-02 Anaphore, Inc. Combinatorial libraries of proteins having the scaffold structure of C-type lectin-like domains
EP1504099A4 (en) * 2001-12-10 2006-05-10 Nuvelo Inc Novel nucleic acids and polypeptides

Also Published As

Publication number Publication date
WO2004005335A2 (en) 2004-01-15
AU2003239777A8 (en) 2004-01-23
WO2004005335A3 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
AU2003239365A1 (en) Recombinant glycosyltransferase fusion proteins
WO2004040000A9 (en) G protein coupled receptors and uses thereof
AU2002342653A1 (en) Modified growth hormone
AU2003219277A1 (en) Intracellular antibodies
AU2003228482A1 (en) Automated protein crystallization imaging
AU2001291049A1 (en) Defensin-antigen fusion proteins
HUP0402496A3 (en) Growth hormone fusion protein
AU2003304235A1 (en) Chemically-modified human growth hormone conjugates
AU2002950188A0 (en) Altered insulin-like growth factor binding proteins
AU2002251972A1 (en) Fusion proteins based upon somatostatin receptors
AU2003222225A1 (en) Receptors and membrane-associated proteins
AU2003226899A1 (en) Human diabetes-mediating proteins
AU2003211112A1 (en) Secreted proteins
AU2003240974A1 (en) Human prolactin antagonist-angiogenesis inhibitor fusion proteins
AU2003206519A1 (en) Alpha-HELICAL PROTEIN BASED MATERIALS AND METHODS FOR MAKING SAME
GB0200689D0 (en) Fusion proteins
AU2003239777A1 (en) Multimerised growth hormone fusion proteins
AU2003238178A1 (en) Pancreas-specific proteins
AU2003263161A1 (en) Method for making recombinant proteins
AU2003222189A1 (en) Secreted proteins
AU2003262638A1 (en) Biotinylation of proteins
AU2003202694A1 (en) Torero protein
AU2003270055A1 (en) Neurotransmission-associated proteins
AU2003236374A1 (en) Atopic dermatitis-inducing proteins
AU2003278718A1 (en) Stars-a muscle-specification-binding protein

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase